PL2029149T3 - Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe - Google Patents

Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe

Info

Publication number
PL2029149T3
PL2029149T3 PL07719706T PL07719706T PL2029149T3 PL 2029149 T3 PL2029149 T3 PL 2029149T3 PL 07719706 T PL07719706 T PL 07719706T PL 07719706 T PL07719706 T PL 07719706T PL 2029149 T3 PL2029149 T3 PL 2029149T3
Authority
PL
Poland
Prior art keywords
progenitor cells
immune privileged
modulatory progenitor
modulatory
privileged
Prior art date
Application number
PL07719706T
Other languages
English (en)
Inventor
John E. Davies
Jane Ennis
Alejandro Gomez-Artistizabal
Dolores Baksh
Original Assignee
John E. Davies
Jane Ennis
Alejandro Gomez-Artistizabal
Dolores Baksh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John E. Davies, Jane Ennis, Alejandro Gomez-Artistizabal, Dolores Baksh filed Critical John E. Davies
Publication of PL2029149T3 publication Critical patent/PL2029149T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07719706T 2006-05-05 2007-05-04 Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe PL2029149T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74650006P 2006-05-05 2006-05-05
PCT/CA2007/000781 WO2007128115A1 (en) 2006-05-05 2007-05-04 Immune privileged and modulatory progenitor cells
EP07719706.9A EP2029149B1 (en) 2006-05-05 2007-05-04 Immune privileged and modulatory progenitor cells

Publications (1)

Publication Number Publication Date
PL2029149T3 true PL2029149T3 (pl) 2017-12-29

Family

ID=38667370

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07719706T PL2029149T3 (pl) 2006-05-05 2007-05-04 Uprzywilejowane immunologicznie i modulacyjne komórki progenitorowe

Country Status (12)

Country Link
US (3) US8277794B2 (pl)
EP (1) EP2029149B1 (pl)
JP (1) JP5431146B2 (pl)
KR (1) KR101507174B1 (pl)
AU (1) AU2007247725B2 (pl)
BR (1) BRPI0710339A2 (pl)
CA (2) CA2649874C (pl)
ES (1) ES2633939T3 (pl)
IL (1) IL195067A (pl)
PL (1) PL2029149T3 (pl)
PT (1) PT2029149T (pl)
WO (1) WO2007128115A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004072273A1 (en) 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
CN103173401A (zh) 2005-12-22 2013-06-26 简·恩尼斯 来自冷冻的脐带组织的活细胞
CA2649874C (en) 2006-05-05 2015-01-27 John E. Davies Immune privileged and modulatory progenitor cells
BRPI0910686A2 (pt) 2008-04-21 2015-09-29 Tissue Regeneration Therapeutics Inc células perivasculares do cordão umbilical humano geneticamente modificadas para a profilaxia contra agentes biológicos e químicos ou para o tratamento dos mesmos.
KR20240052847A (ko) 2008-08-20 2024-04-23 셀룰래리티 인코포레이티드 개선된 세포 조성물 및 그의 제조 방법
CA2734446C (en) 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
JP6104896B2 (ja) 2011-06-01 2017-03-29 アントフロゲネシス コーポレーション 胎盤幹細胞を使用する疼痛の治療
US10400211B1 (en) 2014-04-28 2019-09-03 Donnie Rudd Cell composition for tissue regeneration
US11285177B2 (en) 2018-01-03 2022-03-29 Globus Medical, Inc. Allografts containing viable cells and methods thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE902301A1 (en) 1989-12-22 1991-07-03 Cryo Cell Internat Identification Process And Related Method For Use In¹Preparing A Biological Sample
US5919702A (en) 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US20050158289A1 (en) 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
WO2001011011A2 (en) 1999-08-05 2001-02-15 Mcl Llc Multipotent adult stem cells and methods for isolation
EP1383869B1 (en) 2001-04-24 2009-06-10 Dolores Baksh Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
US20030161818A1 (en) 2002-02-25 2003-08-28 Kansas State University Research Foundation Cultures, products and methods using stem cells
US7736892B2 (en) 2002-02-25 2010-06-15 Kansas State University Research Foundation Cultures, products and methods using umbilical cord matrix cells
WO2004072273A1 (en) * 2003-02-11 2004-08-26 Davies John E Progenitor cells from wharton's jelly of human umbilical cord
AU2004229501B2 (en) 2003-04-11 2011-08-18 Medimmune, Llc Recombinant IL-9 antibodies and uses thereof
WO2005001080A2 (en) 2003-06-27 2005-01-06 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
CA2529718C (en) 2003-06-27 2012-10-23 Universite Laval Method of isolating cells from umbilical cord
WO2005027633A2 (en) 2003-09-16 2005-03-31 21St Century Medicine, Inc. Methods and compositions for the cryopreservation of organs
WO2005085428A1 (en) 2004-03-05 2005-09-15 Davies John E Serum-free suspension culture system for mesenchymal progenitor cells
PL1789534T3 (pl) 2004-08-16 2015-03-31 Cellresearch Corp Pte Ltd Wyodrębnienie komórek macierzystych/progenitorowych z błony owodniowej pępowiny
CN103173401A (zh) 2005-12-22 2013-06-26 简·恩尼斯 来自冷冻的脐带组织的活细胞
WO2007099534A2 (en) 2006-03-01 2007-09-07 The Regenerative Medicine Institute Compostions and populations of cells obtained from the umbilical cord and methods of producing the same
CA2649874C (en) 2006-05-05 2015-01-27 John E. Davies Immune privileged and modulatory progenitor cells

Also Published As

Publication number Publication date
CA2649874C (en) 2015-01-27
JP5431146B2 (ja) 2014-03-05
EP2029149B1 (en) 2017-04-19
CA2871219C (en) 2020-06-30
US8277794B2 (en) 2012-10-02
EP2029149A1 (en) 2009-03-04
ES2633939T3 (es) 2017-09-26
AU2007247725B2 (en) 2013-02-14
KR101507174B1 (ko) 2015-04-01
CA2649874A1 (en) 2007-11-15
WO2007128115A1 (en) 2007-11-15
US8900573B2 (en) 2014-12-02
EP2029149A4 (en) 2012-03-28
JP2009536163A (ja) 2009-10-08
CA2871219A1 (en) 2007-11-15
US20150246079A1 (en) 2015-09-03
PT2029149T (pt) 2017-08-23
US20090285842A1 (en) 2009-11-19
IL195067A0 (en) 2009-08-03
BRPI0710339A2 (pt) 2011-08-09
IL195067A (en) 2015-11-30
US20130089565A1 (en) 2013-04-11
AU2007247725A1 (en) 2007-11-15
KR20090033328A (ko) 2009-04-02

Similar Documents

Publication Publication Date Title
IL195067A0 (en) Immune privileged and modulatory progenitor cells
IL213365A (en) Imidazopyrazine and their pharmaceutical preparations
IL197770A0 (en) Glycerol linked pegylated sugars and glycopeptides
IL225740A0 (en) Adapted factor vii polypeptides and uses thereof
IL221278A0 (en) Chlorotoxin polypeptides and conjugates and uses thereof
ZA201101166B (en) Modified bovine g-csf polypeptides and their uses
GB0712670D0 (en) Isolated peptides and uses thereof
EP2057707A4 (en) INTEGRATED SOLID OXIDE FUEL CELL AND FUEL PROCESSOR
PL2201818T3 (pl) Elektryczny element łączący i szyba zaopatrzona w tego rodzaju element
IL198892A0 (en) Endodermal progenitor cells
GB0720092D0 (en) Improvements in bus stops and bus shelters
EP2360761A4 (en) SEAL STRUCTURE AND FUEL CELL WITH THE SEAL STRUCTURE
EP2146728A4 (en) PROGENITOR CELLS FROM URINE AND METHODS FOR THEIR USE
IL195525A0 (en) Replikin peptides and uses thereof
TWI372866B (en) Peptides specific for hepatocellular carcinoma cells and applications thereof
ZA201104160B (en) Crhr2 peptide agonists and uses thereof
ZA201101853B (en) Fuel compositions comprising limonane and farnesane
IL193921A0 (en) Maduramicin compositions and methods
IL192800A0 (en) Fgf2-binding peptides and uses thereof
GB0800701D0 (en) F10 Polypeptides and uses thereof
GB0710813D0 (en) Peptides and uses thereof
AU2008902600A0 (en) Polypeptides and uses thereof
AU2007905623A0 (en) Improvement in the Distribution and Utilisation of Methanol
AU2007904310A0 (en) Genetically modified cells and uses thereof
HK1162523A (en) Crhr2 peptide agonists and uses thereof